Cancer Causes & Control

, Volume 21, Issue 9, pp 1369–1378 | Cite as

Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers

  • Elaine M. Smith
  • Linda M. Rubenstein
  • Thomas H. Haugen
  • Eva Hamsikova
  • Lubomir P. Turek
Original paper

Abstract

Tobacco, alcohol, and human papillomavirus (HPV) are major risk factors for head and neck cancer (HNC), but it is unclear whether there are two distinct HNC risk groups, one associated with HPV and the other with tobacco/alcohol. Because HPV-positive HNC are clinically distinct from HPV-negative cases in treatment response and with more favorable prognoses, determining whether these differences result from infection alone or in association with other HNC risk factors is important for developing future therapeutic strategies. Incident cases of HNC (n = 201) and age-gender frequency-matched controls (n = 324) were recruited to assess anti-HPV VLP (virus like particles) antibodies 16, 18, 31, and 33. Multivariate logistic regression and stratified analyses were used to calculate adjusted odds ratios (OR). HPV-seronegative and seropositive/heavy tobacco users had similar increased adjusted risks of HNC (HPV-seronegative OR = 2.6, 1.4–5.0; HPV-seropositive OR = 2.3, 1.1–4.8), as did HPV-seronegative (OR = 4.3, 2.1–9.1) versus HPV-seropositive/heavy alcohol users (OR = 3.9, 1.6–9.4). Similar HPV/tobacco/alcohol risk profiles also were seen in oropharyngeal and oral cavity tumor sites. Our finding that tobacco/alcohol use increased the risk of HNC in both HPV-seropositive and HPV-seronegative individuals is consistent with the observation that HPV infection is not a sufficient cause of HNC but requires the accumulation of additional cellular changes.

Keywords

Head and neck neoplasms Tobacco Alcohol Human papillomavirus HPV VLP 

References

  1. 1.
    Franceschi S, Talamini R, Baria S et al (1990) Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy. Cancer Res 50(20):6502–6507PubMedGoogle Scholar
  2. 2.
    Blot WJ, McLaughlin JK, Winn DM et al (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48(11):3282–3287PubMedGoogle Scholar
  3. 3.
    Smith EM, Ritchie JM, Summersgill KF et al (2004) Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96(6):449–455CrossRefPubMedGoogle Scholar
  4. 4.
    Kreimer AR, Clifford GM, Boyle P et al (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14(2):467–475CrossRefGoogle Scholar
  5. 5.
    Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720CrossRefPubMedGoogle Scholar
  6. 6.
    Gillison ML, D’Souza G, Westra W et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100(6):407–420CrossRefPubMedGoogle Scholar
  7. 7.
    Applebaum KM, Furniss CS, Zeka A et al (2007) Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 99(23):1801–1810CrossRefPubMedGoogle Scholar
  8. 8.
    Schwartz SM, Daling JR, Doody DR et al (1998) Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90(21):1626–1636CrossRefPubMedGoogle Scholar
  9. 9.
    Herrero R, Castellsaque X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Instit 95(23):1772–1783Google Scholar
  10. 10.
    Dahlstrom KR, Little JA, Zafereo ME et al (2008) Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck 30(1):75–84CrossRefPubMedGoogle Scholar
  11. 11.
    Psyrri A, DiMaio D (2008) Human papillomavirus in cervical and head-and-neck-cancer. Nat Clin Prac Oncol 5(1):24–31CrossRefGoogle Scholar
  12. 12.
    American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edn. Lippincott Williams and Wilkins, ChicagoGoogle Scholar
  13. 13.
    Smith EM, Rubenstein LM, Ritchie JM et al (2008) Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers? Cancer Epidemiol Biomark Prev 17(8):2087–2096CrossRefGoogle Scholar
  14. 14.
    Hamšíková E, Ludvíková V, Smahel M et al (1998) Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer 77(5):689–694CrossRefPubMedGoogle Scholar
  15. 15.
    Summersgill KF, Smith EM, Kirchner HL et al (2000) p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90(3):334–339CrossRefPubMedGoogle Scholar
  16. 16.
    Chehab FF, Doherty M, Cai SP et al (1987) Detection of sickle cell anaemia and thalassaemias [letter]. Nature 329(6141):293–294CrossRefPubMedGoogle Scholar
  17. 17.
    Ting Y, Manos MM (1990) Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols, a guide to methods and applications. Academic Press, Berkeley, pp 356–367Google Scholar
  18. 18.
    Hildesheim A, Schiffman MH, Gravitt PE et al (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infec Dis 169(2):235–240Google Scholar
  19. 19.
    de Roda Husman A-M, Walboomers JMM, van den Brule AJC et al (1995) The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76(Pt 4):1057–1062CrossRefPubMedGoogle Scholar
  20. 20.
    Altschul SF, Madden TL, Schaeffer AA et al (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acid Res 25(17):3389–3402CrossRefPubMedGoogle Scholar
  21. 21.
    Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3(5):452–456CrossRefPubMedGoogle Scholar
  22. 22.
    Kalilano L, Atashili J (2006) Measuring additive interaction using odds ratios. Epi Perspectives 3:1–10Google Scholar
  23. 23.
    D’Souza G, Kreimer AR, Viscidi R et al (2007) Case-control study of human papillomavirus in oropharyngeal cancer. N Engl J Med 356(19):1944–1956CrossRefPubMedGoogle Scholar
  24. 24.
    Koch WM, Lango M, Sewell D et al (1999) Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 109(10):1544–1551CrossRefPubMedGoogle Scholar
  25. 25.
    Fouret P, Monceaux G, Temam S et al (1997) Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 123(5):513–516PubMedGoogle Scholar
  26. 26.
    Strome SE, Savva A, Brissett AE et al (2002) Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8(4):1093–1100PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Elaine M. Smith
    • 1
  • Linda M. Rubenstein
    • 1
  • Thomas H. Haugen
    • 2
  • Eva Hamsikova
    • 3
  • Lubomir P. Turek
    • 2
  1. 1.Department of Epidemiology, College of Public HealthUniversity of IowaIowa CityUSA
  2. 2.Veterans Affairs Medical Center, and Department of Pathology, Carver College of MedicineUniversity of IowaIowa CityUSA
  3. 3.Department of Experimental VirologyInstitute of Hematology and Blood TransfusionPragueCzech Republic

Personalised recommendations